Speaker Profile
M.D.,Ph.D., Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science & CS, Stanford
Biography
Russ Biagio Altman is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science) and past chairman of Bioengineering at Stanford University. His research uses computing to understand drug action at molecular, cellular, organism and population levels. He founded the PharmGKB, is an Associate Director of the Stanford Institute for HumanCentered AI, and coleads an FDA Center of Excellence. He is a member of the National Academy of Medicine, past president of the International Society for Computational Biology and of the American Society for Clinical Pharmacology Therapeutics. He chaired the FDA Science Board and served on the NIH Directors Advisory Committee. He has received Stanford awards for Teaching and Mentorship. He coorganizes the Pacific Symposium on Biocomputing, and is a founder of Personalis (NASDAQ: PSNL). He is founding editor of the Annual Reviews of Biomedical Data Science, and hosts a podcast entitled "The Future of Everything."
Session Abstract – PMWC 2026 Silicon Valley
Track Chair: TBA
PMWC Award Ceremony Honorees
• Mark Daly, Broad Institute
• Daniel MacArthur, CPG/Genomes/gnomAD
• Gordon Sanghera, Oxford Nanopore
• Howard J. Jacob, Abbvie
The Data Factory: Building Systems to Integrate Millions of Genomes for Variant Interpretation
• Chair: Stephen B. Montgomery, Stanford
• Carlos D. Bustamante, University of Oklahoma
• Mark Daly, Broad Institute/FinnGen
• Manuel Rivas, Stanford
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley
Biobanks to Bedside: Cutting VUS in Cancer, Cardio & Rare—What’s Working Now
• Chair: Ben Neale, Broad Institute
• Daniel MacArthur, CPG/Genomes/gnomAD
Beyond the Read: Integrating Long-Read Data into the Clinical Variant Pipeline
• Chair: Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee P. Ji, Stanford
DNA to FDA: How Genetic Targets Win Labels & Coverage
• Russ B. Altman, Stanford
Common Diseases in Clinical Cohorts – Not Always What They Seem
• Howard J. Jacob, Abbvie
DNA to FDA: How Genetic Targets Win Labels & Coverage
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Russ B. Altman, Stanford
25+ Years of the Human Genome — What Made It to the Bedside
• Chair: Ralph Snyderman, Duke
• J. Craig Venter, Craig Venter Institute (JCVI)
• Brook Byers, KPCB
• Lee Hood, Phenome Health
